background
blood
vessel
tumor
express
higher
level
aminopeptidas
n
apn
compar
normal
tissu
report
peptid
contain
asparagineglycinearginin
ngr
sequenc
home
apn
tumor
vasculatur
increas
express
apn
tumor
vascular
endothelium
therefor
offer
opportun
target
ngr
peptidelink
therapeut
reagent
tumor
determin
whether
addit
ngr
sequenc
could
improv
endotheli
home
biolog
activ
human
endostatin
modifi
genet
introduc
ngr
motif
ngrendostatin
express
yeast
vitro
biolog
activ
ngrendostatin
compar
nativ
protein
endotheli
cell
prolifer
migrat
ngrmodifi
endostatin
use
tumor
local
studi
final
effect
endostatin
ngrendostatin
tumor
growth
determin
two
model
system
sibl
bind
apn
howev
addit
ngrsequenc
amino
terminu
result
strong
bind
inhibit
endotheli
cell
apn
ngrendostatin
show
increas
bind
endotheli
cell
compar
nativ
protein
increas
bind
endostatin
also
coincid
improv
antiangiogen
properti
endostatin
ngr
modif
improv
tumor
local
consequ
effect
inhibit
ovarian
carcinoma
growth
athym
nude
mice
studi
demonstr
human
endostatin
modifi
genet
improv
abil
inhibit
tumor
growth
cancer
ngiogenesi
format
new
blood
vessel
preexist
vasculatur
import
tumor
growth
metastasi
aminopeptidas
n
apn
type
ii
membranebound
metalloproteinas
mr
cleav
amino
termin
residu
biolog
activ
peptid
enkephalin
angiotensin
neurokinin
cytokin
apn
express
variou
epitheli
cell
macrophag
endotheli
cell
origin
describ
lineagespecif
marker
leukemia
appear
coincid
commit
myeloid
lineag
apn
express
exclus
normal
leukem
progeni
myeloid
cell
within
hematopoiet
compart
also
report
apn
receptor
coronaviru
implic
etiolog
sever
acut
respiratori
syndrom
recent
studi
show
apn
express
high
level
tumor
vascu
latur
play
import
role
angiogenesi
uniqu
peptid
contain
ngr
bind
apn
tumor
vasculatur
apn
upregul
respons
hypoxia
angiogen
growth
factor
basic
fibroblast
growth
factor
bfgf
vascular
endotheli
growth
factor
vegf
signal
regul
capillari
tube
format
angiogenesi
antibodi
function
inhibitor
apn
block
retin
neovascular
chorioallanto
membran
angiogenesi
tumor
growth
ngr
motif
use
target
deliveri
tumor
necrosi
factor
tnf
doxorubicin
proapoptot
peptid
liposom
number
proteolyt
fragment
endogen
protein
factor
capabl
inhibit
angiogenesi
former
group
inhibitor
includ
angiostatin
encompass
kringl
plasminogen
endostatin
proteolyt
fragment
collagen
type
xviii
fragment
antithrombin
fragment
collagen
iv
includ
tumstatin
canstatin
arresten
determin
whether
addit
ngr
sequenc
could
improv
endotheli
cell
home
biolog
activ
human
endostatin
modifi
genet
introduc
ngr
motif
express
yeast
although
endostatin
intern
ngr
sequenc
posit
site
access
bind
inhibit
apn
activ
howev
ngr
sequenc
ad
amino
terminu
endostatin
ngrendostatin
apn
activ
inhibit
significantli
ngrendostatin
show
improv
inhibit
tumor
growth
bovin
adren
gland
capillari
endotheli
cell
bce
obtain
clonet
inc
san
diego
ca
human
umbil
vein
endotheli
cell
huvec
passag
kindli
provid
dr
vercelotti
univers
minnesota
human
epitheli
ovarian
carcinoma
cell
line
establish
local
univers
minnesota
patient
stage
iii
epitheli
ovarian
serou
adenocarcinoma
human
primari
melanoma
cell
line
provid
dr
iida
dr
mccarthi
univers
minnesota
human
colon
carcinoma
cell
line
obtain
american
type
cultur
collect
atcc
rockvil
md
mous
ovarian
carcinoma
cell
line
kindli
provid
dr
yokoro
kyoto
univers
japan
human
leukem
monocyt
leukemia
cell
line
highli
metastat
mous
melanoma
cell
line
obtain
atcc
antihuman
apn
monoclon
antibodi
obtain
neomark
fremont
ca
clone
express
condit
human
endostatin
publish
previous
yeast
express
system
pichia
pastori
purchas
invitrogen
san
diego
ca
restrict
enzym
taq
dna
polymeras
purchas
boehring
mannheim
indianapoli
make
ngr
modif
follow
set
primer
use
ttctcgaattcaacgggcgccacagccaccgcgacttccag
ggggcggccgcctacttggaggcagtcatgaagct
amplifi
fragment
purifi
digest
ecorl
notl
clone
vector
plasmid
dna
linear
sacl
site
use
homolog
recombin
yeast
host
strain
invitrogen
electropor
recombin
clone
select
zeocincontain
plate
character
express
endostatin
pichia
clone
cultur
baffl
shaker
flask
induc
methanol
describ
previous
largescal
prepar
ferment
procedur
use
endostatin
ngrendostatin
purifi
heparin
affin
chromatographi
follow
publish
method
heparin
column
equilibr
mm
trishcl
buffer
ph
mm
phenylmethylsulfonyl
fluorid
pmsf
sampl
appli
column
flow
rate
ml
per
minut
fastperform
liquid
chromatographi
amersham
pharmacia
biotech
piscataway
nj
thorough
wash
remov
unbound
protein
bound
protein
elut
continu
gradient
nacl
mm
trishcl
ph
mm
pmsf
endostatin
ngrendostatin
elut
nacl
purifi
endostatin
analyz
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
electrophoresi
gel
acrylamid
gel
reduc
condit
express
level
apn
varieti
cell
line
analyz
flow
cytometri
cell
detach
mm
ethylenediamin
tetraacet
acid
edta
phosphatebuff
salin
pb
wash
hank
balanc
salt
solut
hbss
cell
fix
icecold
paraformaldehyd
wash
cell
hbss
monoclon
antibodi
apn
dilut
ad
cell
fluorescein
isothiocyan
fitc
conjug
antimous
immunoglobulin
g
use
second
antibodi
apn
extract
cell
describ
see
result
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
pmsf
gml
leupeptin
mm
ovanad
mm
nethylmaleimid
tritonx
enzymat
activ
determin
use
mg
mole
alanin
pnitroanilid
substrat
cell
lysat
g
protein
incub
reaction
buffer
presenc
absenc
inhibitor
hour
apn
activ
measur
chang
absorb
nanomet
nm
bestatin
known
apn
inhibitor
use
posit
control
leupeptin
serin
proteas
inhibitor
use
neg
control
one
nanomolar
per
well
either
endostatin
ngrendostatin
gelatin
use
coat
enzymelink
immunoadsorb
assay
elisa
plate
plate
incub
overnight
block
bovin
serum
albumin
bsa
pb
hour
huvec
cell
harvest
mm
edta
pb
prelabel
minut
carboxi
fluorescein
diacet
succinimidyl
ester
cfda
vital
fluoresc
dye
molecular
probe
eugen
wash
hbss
fluorescencelabel
cell
resuspend
endotheli
growth
medium
huvec
cell
medium
cell
cell
ad
well
densiti
cell
per
well
incub
plate
wash
twice
hbss
remov
unbound
cell
cell
bound
well
detect
fluoresc
plate
reader
cyto
fluor
ii
persept
biosystem
framingham
excit
nm
emiss
nm
essenti
method
describ
oreilli
et
al
use
confluent
bce
cell
trypsin
resuspend
invitrogen
medium
fetal
bovin
serum
fb
cell
seed
gelatin
cultur
plate
densiti
cell
per
well
hour
endostatin
ngrendostatin
ad
concentr
gml
twenti
minut
later
cultur
treat
ngml
bfgf
invitrogen
viabil
control
cell
treat
cell
determin
incorpor
roch
indianapoli
accord
manufactur
instruct
migrat
endotheli
cell
determin
use
boyden
chamber
neuro
probe
gaithersburg
md
polycarbon
filter
pore
size
coat
gelatin
hour
huvec
cell
harvest
mm
edta
pb
prelabel
cfda
minut
cell
resuspend
fb
medium
preincub
endostatin
ngrendostatin
ngrcontain
peptid
minut
bfgf
l
ngml
fb
medium
ad
lower
chamber
huvec
cell
cellsml
control
treat
ad
upper
chamber
hour
incub
endotheli
cell
migrat
bottom
side
membran
observ
fluoresc
microscop
olympu
melvil
ny
use
fitc
filter
magnif
captur
imag
quantifi
adob
photoshop
adob
system
inc
san
jose
ca
metamorph
molecular
devic
corpor
downingtown
pa
program
two
independ
experi
perform
cell
inject
subcutan
side
flank
femal
athym
nude
mice
age
week
tumor
size
reach
mm
volum
day
tumorbear
mice
random
two
group
control
group
seven
mice
experiment
group
eight
mice
endostatin
ngrendostatin
inject
dose
mgkg
subcutan
nineteen
hour
inject
tumor
tissu
tumor
sampl
respect
group
repres
normal
tissu
remov
surgic
time
point
chosen
minim
overwhelm
serum
level
obscur
tissuebound
endostatin
tissu
snap
frozen
homogen
ripa
buffer
contain
proteinas
inhibitor
pb
sodium
deoxychol
sd
gml
pmsf
maintain
minut
clear
centrifug
human
endostatin
concentr
serum
tissu
lysat
determin
elisa
cytimmun
colleg
park
md
elisa
method
show
similar
sensit
nativ
endostatin
ngrendostatin
data
shown
statist
signific
determin
student
test
femal
athym
nude
mice
age
week
obtain
nation
cancer
institut
acclimat
local
condit
week
logarithm
grow
mous
ovarian
carcinoma
cell
harvest
trypsin
suspend
fresh
medium
densiti
cellsml
l
singlecel
suspens
inject
subcutan
flank
mice
tumor
becam
visibl
day
inocul
mice
random
group
mice
treat
endostatin
ngrendostatin
subcutan
dose
mgkg
per
day
day
control
group
mice
n
anim
treat
steril
pb
similar
condit
inject
given
subcutan
cm
away
grow
tumor
mass
tumor
growth
monitor
period
calip
measur
tumor
volum
calcul
follow
formula
tumor
volum
mm
b
length
mm
b
width
mm
b
statist
signific
control
treat
group
determin
student
test
endostatinencapsul
algin
bead
prepar
describ
previous
control
group
mice
receiv
vehicleencapsul
algin
bead
similar
schedul
algin
acid
natur
occur
biopolym
use
matrix
entrap
deliveri
varieti
biolog
agent
logarithm
grow
cell
harvest
trypsin
suspend
serumfre
medium
densiti
cellsml
l
singlecel
suspens
inject
subcutan
flank
femal
athym
mice
tumor
becam
visibl
day
inocul
mice
random
group
treat
endostatinencapsul
algin
bead
anim
per
group
algin
microencapsult
result
slow
sustain
releas
vivo
endostatin
prepar
given
week
total
four
inject
studi
statist
signific
control
treat
group
determin
student
test
determin
effect
antiangiogen
treatment
vessel
densiti
apoptosi
residu
tumor
resect
surgic
snap
frozen
liquid
nitrogen
cryostat
section
tumor
fix
cold
aceton
air
dri
treat
pb
contain
bsa
block
nonspecif
bind
background
section
incub
dilut
mous
monoclon
antibodi
conjug
phycoerythrin
mec
bd
pharmingen
san
diego
ca
incub
room
temperatur
section
wash
thoroughli
pb
examin
olympu
fluoresc
microscop
imag
field
per
section
captur
metamorph
program
analysi
detect
apoptosi
carri
use
situ
cell
death
detect
kit
boehring
mannheim
indianapoli
follow
manufactur
protocol
part
tumor
sampl
also
fix
neutral
buffer
formalin
process
histolog
initi
experi
perform
determin
express
level
apn
ovarian
carcinoma
cell
line
melanoma
cell
line
endotheli
cell
line
use
flowcytometr
analysi
fig
huvec
cell
express
rel
larger
amount
apn
compar
ovarian
melanoma
tumor
cell
line
flowcytometr
data
show
almost
huvec
cell
posit
apn
express
next
examin
function
level
apn
lysat
number
cell
line
includ
monocytoid
cell
reportedli
express
apn
apn
involv
degrad
extracellular
matrix
ecm
invas
metastat
tumor
cell
highli
metastat
mous
melanoma
cell
line
includ
studi
apn
activ
huvec
cell
lysat
much
greater
compar
apn
activ
carcinoma
cell
line
fig
bfgf
treatment
increas
apn
activ
dramat
huvec
cell
fig
incub
bfgf
concentr
ngml
apn
activ
huvec
cell
time
greater
activ
huvec
cell
without
bfgf
treatment
data
suggest
proangiogen
growth
factor
increas
apn
activ
coincid
endotheli
cell
sprout
show
previous
intern
ngr
sequenc
endostatin
access
apn
therefor
endostatin
inhibit
apn
endostatin
modifi
genet
incorpor
ngr
motif
nterminu
modifi
endostatin
investig
abil
inhibit
apn
endostatin
contain
rgd
sequenc
use
neg
control
bestatin
inhibit
apn
activ
huvec
cell
lysat
endostatin
endostatinrgd
affect
apn
activ
howev
ngrendostatin
inhibit
apn
activ
concentr
fig
determin
whether
addit
ngr
motif
endostatin
enhanc
bind
endotheli
cell
cellattach
assay
perform
posit
control
gelatinco
well
use
extent
huvec
cell
attach
gelatinco
well
use
bind
calcul
rel
effici
endostatinmedi
cell
attach
bsablock
well
use
neg
control
compar
gelatin
endostatinco
well
show
cell
attach
fig
ngr
modif
endostatin
enhanc
vitro
bind
endotheli
cell
ngrendostatin
show
cell
attach
differ
signific
contrast
huvec
cell
apnposit
melanoma
cell
apnneg
posit
fig
apnneg
cell
show
increas
attach
ngrendostatin
nativ
endostatin
ngrendostatin
show
similar
level
basal
attach
fig
whether
ngr
motif
affect
abil
endostatin
inhibit
endotheli
cell
prolifer
evalu
fig
bfgf
ngml
use
induc
endotheli
cell
prolifer
endostatin
treatment
gml
inhibit
bfgfinduc
prolifer
compar
nativ
protein
ngrendostatin
treatment
huvec
cell
show
mark
improv
inhibit
cell
prolifer
ngrendostatin
show
inhibit
differ
statist
signific
p
evalu
whether
ngr
motif
affect
abil
endostatin
inhibit
endotheli
cell
migrat
boyden
chamberbas
migrat
assay
perform
fig
bfgf
use
induc
endotheli
cell
migrat
endostatin
treatment
nm
show
inhibit
bfgfinduc
migrat
howev
ngrmodifi
endostatin
show
complet
inhibit
bfgfinduc
endotheli
cell
migrat
nm
higher
concentr
ngrendostatin
show
inhibit
indic
even
basal
migrat
absenc
bfgf
inhibit
ngrendostatin
parallel
studi
ngrcontain
synthet
peptid
admix
nativ
endostatin
determin
whether
presenc
ngrpeptid
medium
suffici
chang
biolog
activ
nativ
endostatin
data
illustr
figur
show
admix
nm
endostatin
along
ngr
synthet
peptid
alter
basal
level
endostatinmedi
inhibit
cell
migrat
result
studi
suggest
ngr
moieti
integr
part
endostatin
potenti
biolog
activ
endostatin
assess
whether
improv
endotheli
cell
bind
vitro
translat
enhanc
tumor
home
vivo
tumor
local
studi
perform
endostatin
ngrendostatin
inject
subcutan
human
colon
carcinomabear
athym
mice
tumor
lung
liver
serum
sampl
figur
nativ
endostatin
accumul
tumor
tissu
level
nmolemg
tissu
similar
condit
ngrendostatin
show
higher
concentr
tumor
tissu
nmolemg
tissu
increas
home
ngrendostatin
statist
signific
determin
whether
ngrendostatin
could
improv
antitumor
activ
endostatin
use
two
tumor
model
system
first
model
system
use
mous
ovarian
carcinoma
cell
line
second
model
use
human
ovarian
carcinoma
cell
line
athym
nude
mous
first
model
system
bolu
inject
endostatin
test
ngrendostatin
endostatin
administ
subcutan
dose
mgkg
per
day
durat
studi
model
system
control
tumor
grew
rapidli
reach
size
mm
day
bolu
inject
nativ
endostatin
inhibit
tumor
growth
day
fig
similar
condit
ngrendostatin
treatment
show
inhibit
ngrendostatin
inhibit
tumor
growth
cell
effici
compar
nativ
endostatin
fig
nativ
endostatintr
anim
show
inhibit
tumor
growth
tumor
growth
inhibit
improv
significantli
treatment
ngrendostatin
approxim
inhibit
observ
ngrendostatintr
group
day
statist
signific
throughout
experi
ngrendostatintr
group
show
reduc
tumor
volum
compar
nativ
endostatintr
group
figur
show
endostatin
treatment
ngrendostatin
treatment
reduc
blood
vessel
branch
point
node
end
length
significantli
ngr
motif
enhanc
antiangiogen
effect
endostatin
end
length
blood
vessel
significantli
termin
deoxyuridin
triphosph
nickend
label
hematoxylin
eosin
stain
reveal
ngrmodifi
endostatin
induc
apoptosi
tumor
tissu
correl
inadequ
angiogenesi
quantit
analysi
apoptot
index
shown
figur
endostatintr
tumor
tissu
show
apoptot
cell
per
field
wherea
control
tissu
show
apoptot
cell
per
field
greater
number
apoptot
cell
seen
ngrendostatintr
mice
mean
apoptot
cell
per
field
seen
ngrendostatintr
group
transmembran
proteas
membran
type
matrix
metalloproteinas
adam
disintegrin
metalloproteas
capabl
degrad
ecm
lead
tumor
cell
invas
proteolysi
ecm
also
releas
sequest
angiogen
molecul
report
apn
mediat
migrat
human
metastat
cell
line
matrigel
apn
also
play
import
role
angiogenesi
apn
express
prognost
patient
colon
carcinoma
recent
studi
shown
function
antagonist
apn
bestatin
actinonin
antiapn
antibodi
inhibit
tube
format
motil
endotheli
cell
without
alter
prolifer
recombin
endostain
clone
express
differ
express
system
model
system
endostatin
treatment
either
inhibit
regress
experiment
tumor
studi
show
moder
inhibit
bacteri
express
system
often
result
insolubl
protein
necessit
refold
protocol
suggest
slow
releas
endostatin
insolubl
suspens
coupl
proper
refold
vivo
respons
potent
inhibit
angiogenesi
tumor
growth
kranenburg
et
al
report
denatur
insolubl
form
endostatin
show
better
bioactiv
solubl
form
endostatin
kruger
et
al
demonstr
differ
efficaci
calbiochemendostatin
entremedendostatin
genet
express
human
endostatin
bacteria
yeast
seem
affect
biolog
activ
differ
potenc
solubl
characterist
reflect
part
protein
fold
may
explain
differ
seen
endostatin
efficaci
vivo
understand
basi
discrep
aid
success
clinic
develop
endostatin
show
previous
antiangiogen
activ
endostatin
improv
ad
integrintarget
rgd
sequenc
tumor
blood
vessel
express
higher
level
v
v
integrin
rgd
motif
increas
tumor
local
bioavail
endostatin
current
studi
evalu
whether
ngr
motif
also
could
potenti
activ
endostatin
virtu
bind
apn
express
endotheli
cell
show
ngr
motif
increas
endotheli
cell
attach
specif
apn
express
ngrendostatin
alter
basal
bind
apnneg
melanoma
cell
data
present
current
studi
valid
find
intern
ngr
sequenc
present
nativ
endostatin
access
bind
apn
inhibit
enzymat
activ
addit
ngr
motif
endostatin
show
signific
inhibit
apn
activ
endotheli
cell
lysat
furthermor
ngr
sequenc
amino
terminu
endostatin
enhanc
efficaci
endostatin
inhibit
endotheli
cell
prolifer
migrat
curni
et
al
show
similar
modif
tnf
alter
affin
biolog
activ
vitro
howev
ngr
motif
improv
efficaci
tnf
vivo
current
studi
observ
addit
ngr
sequenc
endostatin
increas
bind
endotheli
cell
enhanc
biolog
activ
improv
biolog
activ
seen
nativ
endostatin
admix
ngr
peptid
result
suggest
enhanc
inhibit
endotheli
cell
depend
ngr
motif
associ
endostatin
previou
studi
doxorubicin
conjug
ngr
peptid
show
less
toxic
tumor
cell
vitro
hour
compar
unconjug
doxorubicin
howev
ngrconjug
doxorubicin
show
better
efficaci
vitro
short
exposur
minut
inhibit
tumor
growth
vivo
better
compar
unconjug
doxorubicin
ellerbi
et
al
show
biolog
activ
proapoptot
peptid
klaklak
improv
vitro
vivo
ngr
motif
recent
bhagwat
et
al
show
inhibit
angiogen
signal
transduct
pathway
restor
overexpress
apn
therefor
blockag
apn
activ
ngr
motif
antiangiogen
effect
endostatin
could
act
synergist
apn
express
highli
tumor
vasculatur
ngrmotif
home
apn
possibl
target
therapeut
molecul
tumor
vasculatur
pastorino
et
al
show
liposom
coupl
ngr
longer
circul
profil
blood
higher
tumor
local
compar
uncoupl
liposom
ngrendostatin
also
local
tumor
tissu
higher
level
compar
nativ
endostatin
increas
accumul
ngrendostatin
correl
greater
antiangiogen
effect
vivo
morphometr
analysi
reveal
ngrendostatin
treatment
reduc
vessel
densiti
residu
tumor
decreas
number
blood
vessel
coincid
increas
apoptosi
tumor
tissu
result
studi
suggest
ngr
modif
angiostat
molecul
endostatin
use
improv
therapeut
efficaci
